Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06545045 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cognitive Rehabilitation Following Breast Cancer Treatment

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jun 30, 2026 → Jun 30, 2027
See other at-risk trials from University of Missouri-Columbia

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jun 30, 2026 to Jun 30, 2027
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 7 of 9 entries
    • Publications: details revised at 10 of 11 entries
  2. Primary and study completion dates: Dec 30, 2025 to Jun 30, 2026v6
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v5
  4. Start date: Sep 30, 2024 to Oct 31, 2024v4
  5. Start date: Aug 30, 2024 to Sep 30, 2024v3
  6. Study description revisedv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this proposed project is to evaluate the feasibility and preliminary effect of metacognitive strategy training to improve activity performance, cognition, and quality of life in breast cancer survivors with cancer-related cognitive impairment (CRCI). The other goal of this proposed project is to examine the effects of CO-OP on resting (rsFC)- and task-state functional connectivity as compared to an inactive control group.
Trial Details
NCT Number NCT06545045
Lead Sponsor University of Missouri-Columbia
Collaborators: National Institutes of Health (NIH), National Cancer Institute (NCI)
Conditions
(from sponsor)		 Breast Cancer Female
Related terms Breast Neoplasms, Neoplasms
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov